Oral suspension of tegaserod

Details for Australian Patent Application No. 2004226797 (hide)

Owner Novartis AG

Inventors Bizot, Marie-Noelle; Vitzling, Christian; Iwicki, Mark Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2004226797

PCT Pub. Number WO2004/087135

Priority 0307440.8 31.03.03 GB

Filing date 30 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 3 May 2007

International Classifications

A61K 31/4045 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/46 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Ingredients of undetermined constitution or reaction products thereof

Event Publications

29 September 2005 PCT application entered the National Phase

  PCT publication WO2004/087135 Priority application(s): WO2004/087135

3 May 2007 Application Accepted

  Published as AU-B-2004226797

30 August 2007 Standard Patent Sealed

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226798-Swab for collecting biological specimens

2004226796-Pressure generating unit